Keloid Treatment Market to Reach USD 5.6 Billion by 2033 at a 3.8% of CAGR, Driven by Advancements in Aesthetic and Nonsurgical Treatments

The keloid treatment market is witnessing steady growth, with its valuation projected to increase from USD 3.8 billion in 2023 to USD 5.6 billion by 2033, expanding at a CAGR of 3.8% during the forecast period. This growth is driven by rising cases of keloids and hypertrophic scars, along with advancements in treatment methods.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰: https://www.futuremarketinsights.com/report-sample#5245502d47422d31333133

Among various treatment options, the intralesional corticosteroid injections segment remains dominant, holding 28.3% of the market share in 2021. This trend is expected to continue, as corticosteroid injections are widely used to reduce inflammation, improve scar appearance, and minimize recurrence rates.

Keloid formation is linked to cutaneous injuries and skin irritation caused by trauma, burns, acne, surgery, and infections. With the increasing number of road accidents, burn cases, and the growing demand for aesthetic procedures, the adoption of nonsurgical treatments that improve scar appearance and restore skin function is on the rise.

The global keloid treatment market accounted for 29.5% of the overall USD 14.1 billion scar treatment market in 2021, and this share is expected to increase further as new and innovative treatment approaches continue to emerge.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬:

The keloid treatment market is projected to grow from USD 3.8 billion in 2023 to USD 5.6 billion by 2033, with a CAGR of 3.8%.
Intralesional corticosteroid injections remain the most dominant treatment method, with a 28.3% market share in 2021.
Keloids and hypertrophic scars result from various skin injuries, including burns, acne, surgery, and trauma.
Rising burn cases, road accidents, and the popularity of aesthetic surgeries are driving demand for advanced keloid treatment options.
The keloid treatment market made up 29.5% of the global scar treatment market in 2021, and its share is expected to grow.

𝐆𝐞𝐭 𝐭𝐡𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰 - https://www.futuremarketinsights.com/reports/keloid-treatment-market

𝐊𝐞𝐲 𝐟𝐚𝐜𝐭𝐨𝐫𝐬 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐫𝐨𝐰𝐭𝐡:

Rising incidence of keloids: Keloids, characterized by abnormal scar tissue growth, are becoming a widespread concern globally, increasing the demand for effective treatment solutions. Keloids and hypertrophic scars result from cutaneous injuries and irritation, including trauma, insect bites, burns, surgery, vaccinations, skin piercing, acne, folliculitis, chicken pox, and herpes zoster infection.
Advancements in treatment approaches: Developments in medical technologies and increased awareness are contributing to the demand for optimal scar management solutions. Innovations in keloid treatments are expected to provide various market growth opportunities.
Increased road accidents and burn cases: A rise in road accidents and burn cases is also fueling the growth of the keloid treatment market. These incidents often result in visible keloid scars, a common complication that drives the demand for treatment.
Growing popularity of aesthetic surgeries: The rising popularity of aesthetic surgeries is contributing to the expansion of the keloid treatment market.

𝐆𝐫𝐨𝐰𝐢𝐧𝐠 𝐩𝐨𝐩𝐮𝐥𝐚𝐫𝐢𝐭𝐲 𝐨𝐟 𝐚𝐞𝐬𝐭𝐡𝐞𝐭𝐢𝐜 𝐬𝐮𝐫𝐠𝐞𝐫𝐢𝐞𝐬?

Several non-surgical treatments have proven effective in managing keloids:

Corticosteroid Injections: Intralesional corticosteroid injections, particularly triamcinolone acetonide (IL TAC), are a first-line treatment option. They reduce inflammation, suppress mitosis, and increase vasoconstriction within the scar tissue, ultimately flattening the keloid. While generally effective, repeated sessions may be necessary, and the procedure can be painful.
Silicone Gel or Sheeting: Silicone elastomer sheets are a non-invasive approach to both prevent and treat keloids. They are thought to work by increasing the temperature, hydration, and oxygen tension of the occluded scar, causing it to soften and flatten. Applying silicone gel or sheeting directly to the scar helps hydrate the area and reduce its size and appearance over time.
Cryotherapy: This technique involves freezing the keloid tissue with liquid nitrogen, leading to its gradual reduction. Cryotherapy is more suitable for smaller keloids and may require multiple sessions for effective results. It transitions keloidal fibroblasts towards a normal fibroblastic phenotype, increasing the ratio of type 3 to type 1 collagen in vitro.
Pressure Therapy: Pressure dressings made from stretchy fabric or other materials can be used for newer keloids.
Other non-invasive treatments: Some studies support using onion extract for keloids. A 2013 study found that onion extract stopped fibroblasts-the cells that produce scar tissue-from entering the skin.

𝐊𝐞𝐲 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐏𝐫𝐨𝐟𝐢𝐥𝐞𝐝

Novartis AG; Sensus Healthcare; RXi Pharmaceuticals, Inc.; Sonoma Pharmaceuticals, Inc.; Perrigo Company plc.; Bristol-Myers Squibb Company; Pacific World Corporation; Valeant Pharmaceuticals International, Inc.; Revitol Corporation; Avita Medical Limited

𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜 𝐃𝐞𝐯𝐢𝐜𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬: 𝐊𝐞𝐲 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐬 & 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐀𝐜𝐫𝐨𝐬𝐬 𝟏𝟓+ 𝐂𝐨𝐮𝐧𝐭𝐫𝐢𝐞𝐬 - https://www.futuremarketinsights.com/industry-analysis/therapeutic-device

𝐊𝐞𝐥𝐨𝐢𝐝 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

By Treatment:

Occlusive Dressing

Compression Therapy

Cryosurgery

Excision

Radiation Therapy

Laser Therapy

Interferon Therapy

Intralesional Corticosteroid Injections

Others

By End User:

Hospitals

Dermatology Clinics

Ambulatory Surgical Centers (ASCs)

Others

By Region:

North America

Latin America

Europe

East Asia

South Asia

Oceania

The Middle East & Africa (MEA)

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐅𝐌𝐈'𝐬 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐎𝐧𝐠𝐨𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐃𝐨𝐦𝐚𝐢𝐧:

United States Cold Laser Therapy Industry Outlook from 2025 to 2035 - https://www.futuremarketinsights.com/reports/united-states-cold-laser-therapy-market

UK Cold Laser Therapy Industry Outlook from 2025 to 2035 - https://www.futuremarketinsights.com/reports/uk-cold-laser-therapy-market

UK Foley Catheter Industry Outlook from 2025 to 2035 - https://www.futuremarketinsights.com/reports/uk-foley-catheter-market

Canada High Tibial Osteotomy (HTO) Plates Industry Outlook from 2025 to 2035 - https://www.futuremarketinsights.com/reports/canada-high-tibial-osteotomy-plates-market

Japan High Tibial Osteotomy (HTO) Plates Industry Outlook from 2025 to 2035 - https://www.futuremarketinsights.com/reports/japan-high-tibial-osteotomy-plates-market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

This release was published on openPR.